DOP2011000031A - Vacuna contra el virus del papiloma humano(hpv) - Google Patents

Vacuna contra el virus del papiloma humano(hpv)

Info

Publication number
DOP2011000031A
DOP2011000031A DO2011000031A DO2011000031A DOP2011000031A DO P2011000031 A DOP2011000031 A DO P2011000031A DO 2011000031 A DO2011000031 A DO 2011000031A DO 2011000031 A DO2011000031 A DO 2011000031A DO P2011000031 A DOP2011000031 A DO P2011000031A
Authority
DO
Dominican Republic
Prior art keywords
hpv
vaccine against
papiloma virus
human papiloma
human
Prior art date
Application number
DO2011000031A
Other languages
English (en)
Spanish (es)
Inventor
Dominique Descamps
Sandra Giannini
Nicolas Lecrenier
Jean Stephenne
Martine Anne Cecile Wettendorff
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of DOP2011000031A publication Critical patent/DOP2011000031A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DO2011000031A 2008-07-31 2011-01-28 Vacuna contra el virus del papiloma humano(hpv) DOP2011000031A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8510108P 2008-07-31 2008-07-31
US17656109P 2009-05-08 2009-05-08

Publications (1)

Publication Number Publication Date
DOP2011000031A true DOP2011000031A (es) 2011-02-28

Family

ID=41139260

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000031A DOP2011000031A (es) 2008-07-31 2011-01-28 Vacuna contra el virus del papiloma humano(hpv)

Country Status (26)

Country Link
US (1) US20110189229A1 (enExample)
EP (1) EP2318042B1 (enExample)
JP (1) JP6022159B2 (enExample)
KR (1) KR20110053340A (enExample)
CN (1) CN102159239A (enExample)
AU (1) AU2009275909A1 (enExample)
BR (1) BRPI0916732B1 (enExample)
CA (1) CA2732436C (enExample)
CO (1) CO6341567A2 (enExample)
DK (1) DK2318042T3 (enExample)
DO (1) DOP2011000031A (enExample)
EA (1) EA201170264A1 (enExample)
ES (1) ES2519490T3 (enExample)
HR (1) HRP20141063T1 (enExample)
IL (1) IL210977A0 (enExample)
MA (1) MA32554B1 (enExample)
MX (1) MX2011001218A (enExample)
NZ (1) NZ590919A (enExample)
PE (1) PE20110327A1 (enExample)
PL (1) PL2318042T3 (enExample)
PT (1) PT2318042E (enExample)
RS (1) RS53607B1 (enExample)
SI (1) SI2318042T1 (enExample)
SM (1) SMT201400170B (enExample)
WO (1) WO2010012780A1 (enExample)
ZA (1) ZA201100889B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010264695A1 (en) 2009-06-25 2012-01-19 Glaxosmithkline Biologicals S.A. Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease
CN102178944A (zh) * 2010-09-17 2011-09-14 大连雅立峰生物制药有限公司 人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh) * 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
AU2015313756A1 (en) * 2014-09-11 2017-03-09 Cadila Healthcare Limited Superior human papilloma virus antigens with superior immunological properties and vaccine containing it
US10063211B2 (en) 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
RU2628693C1 (ru) * 2016-11-10 2017-08-21 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ
US20210302427A1 (en) * 2020-03-31 2021-09-30 Shuhari Group, LLC Secure Immunity Information Transmission System And Network
WO2025147639A1 (en) * 2024-01-04 2025-07-10 Cyanvac Llc Improved formulation providing increased stability for vaccines composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
WO2005089164A2 (en) * 2003-12-31 2005-09-29 Pharmexa Inc. Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
US7758866B2 (en) * 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
WO2005123125A1 (en) * 2004-06-16 2005-12-29 Glaxosmithkline Biologicals S.A. Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
WO2006114312A2 (en) * 2005-04-26 2006-11-02 Glaxosmithkline Biologicals S.A. Vaccine

Also Published As

Publication number Publication date
ZA201100889B (en) 2012-04-25
AU2009275909A1 (en) 2010-02-04
CA2732436A1 (en) 2010-02-04
PE20110327A1 (es) 2011-06-29
EP2318042A1 (en) 2011-05-11
PT2318042E (pt) 2014-11-05
WO2010012780A1 (en) 2010-02-04
HRP20141063T1 (hr) 2015-01-02
MX2011001218A (es) 2011-03-15
ES2519490T3 (es) 2014-11-07
IL210977A0 (en) 2011-04-28
CO6341567A2 (es) 2011-11-21
NZ590919A (en) 2012-10-26
MA32554B1 (fr) 2011-08-01
JP2011529475A (ja) 2011-12-08
BRPI0916732A2 (pt) 2017-01-31
SMT201400170B (it) 2015-01-15
RS53607B1 (sr) 2015-04-30
JP6022159B2 (ja) 2016-11-09
PL2318042T3 (pl) 2015-02-27
CA2732436C (en) 2018-01-16
KR20110053340A (ko) 2011-05-20
DK2318042T3 (da) 2014-11-10
CN102159239A (zh) 2011-08-17
EA201170264A1 (ru) 2011-08-30
SI2318042T1 (sl) 2014-12-31
EP2318042B1 (en) 2014-08-20
US20110189229A1 (en) 2011-08-04
BRPI0916732B1 (pt) 2021-06-29

Similar Documents

Publication Publication Date Title
DOP2011000031A (es) Vacuna contra el virus del papiloma humano(hpv)
EP2632485A4 (en) DENGUE VIRUS VACCINE WITH A RECOMBINANT SUB-UNIT
DK3108933T3 (da) Indretninger til minimal-invasiv extraokulær levering af radiation til posterior del af øjet
ZA201004688B (en) Novel vaccines against multiple subtypes of dengue virus
BRPI1011224A2 (pt) vacina contra vírus da dengue inativado com adjuvante livre de alumínio
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
CO6811814A2 (es) Vacuna de virus dengue inactivado
EP2394564A4 (en) MEDICAL TUBUS
EP2461764A4 (en) DENTAL UNIT
EP2398892A4 (en) LIVING WEARED VACCINES
SG11201500439RA (en) Vaccine compositions for prevention against dengue virus infection
BR112012007861A2 (pt) dispositivos médicos e suas bombas
EP2595653A4 (en) INFLUENZA VACCINE
IT1393136B1 (it) Procedimento per la preparazione del bosentan
EP2484378A4 (en) HEPATITIS C VIRUS VACCINE COMPOSITION
BRPI1013722A2 (pt) seringa dental
EP2516629A4 (en) VACCINES AGAINST HERPES SIMPLEX VIRUS
BRPI0920622A2 (pt) vacina contra vírus da doença equina africana
CU24060B1 (es) Composición vacunal contra el virus del dengue, kit y plásmido
EP2543387A4 (en) MUCOSA VACCINE
BR112012011009A2 (pt) vacinas contra tripanossomíase e diagnóstico
EP2498815A4 (en) VACCINE COMPOSITION
SMT201400045B (it) Dispositivo di derivazione per influenzare la pressione danguigna
BRPI1013903A2 (pt) tratamentos terapêuticos utilizando centaquina
BR112013008078A2 (pt) tratamentos de infecção por vírus da hepatite c